Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;145(4):1295-1297.e6.
doi: 10.1016/j.jaci.2019.12.009. Epub 2019 Dec 19.

Severe asthma in the US population and eligibility for mAb therapy

Ayobami Akenroye  1 , Meredith McCormack  2 , Corinne Keet  3
Affiliations

Severe asthma in the US population and eligibility for mAb therapy

Ayobami Akenroye et al. J Allergy Clin Immunol. 2020 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.

Figures

FIG 1.
FIG 1.
For the heat map, the value in the cell reflects what percentage of participants eligible for the biologic in the row (A-E) were eligible for the biologics in the column. For instance, 73% of participants eligible for omalizumab were eligible for mepolizumab but only 44% of those eligible for mepolizumab were eligible for omalizumab.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. Asthma surveillance data. Available at: https://www.cdc.gov/asthma/asthmadata.htm. Accessed April 23, 2019.
    1. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343–73. - PubMed
    1. Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015;135:896–902. - PubMed
    1. Hambly N, Nair P. Monoclonal antibodies for the treatment of refractory asthma. Curr Opin Pulm Med 2014;20:87–94. - PubMed
    1. Lee J, Tay TR, Radhakrishna N, Hore-Lacy F, Mackay A, Hoy R, et al. Nonadherence in the era of severe asthma biologics and thermoplasty. Eur Respir J 2018;51:1701836. - PMC - PubMed

Publication types

MeSH terms